Report Detail

Other Global Radiocontrast Agent Market Insights, Forecast to 2025

  • RnM2989367
  • |
  • 20 February, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Other

Global Radiocontrast Agent market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Radiocontrast Agent.

This report researches the worldwide Radiocontrast Agent market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Radiocontrast Agent breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the top manufacturers' Radiocontrast Agent capacity, production, value, price and market share of Radiocontrast Agent in global market. The following manufacturers are covered in this report:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

Radiocontrast Agent Breakdown Data by Type
By Type
Barium-based Radiocontrast Agent
Iodinated Radiocontrast Agent
Gadolinium-based Radiocontrast Agent
Microbubble Radiocontrast Agent
By Modality
X-ray/Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
By Route of Administration
Oral
Intravascular
Rectal
Others
Radiocontrast Agent Breakdown Data by Application
Radiology
Interventional Radiology
Interventional Cardiology

Radiocontrast Agent Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Radiocontrast Agent Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Radiocontrast Agent capacity, production, value, consumption, status and forecast;
To focus on the key Radiocontrast Agent manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Radiocontrast Agent :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Radiocontrast Agent Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Radiocontrast Agent Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Radiocontrast Agent Market Size Growth Rate by Type
        • 1.4.2 Barium-based Radiocontrast Agent
        • 1.4.3 Iodinated Radiocontrast Agent
        • 1.4.4 Gadolinium-based Radiocontrast Agent
        • 1.4.5 Microbubble Radiocontrast Agent
      • 1.5 Market by Application
        • 1.5.1 Global Radiocontrast Agent Market Size Growth Rate by Application
        • 1.5.2 Radiology
        • 1.5.3 Interventional Radiology
        • 1.5.4 Interventional Cardiology
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Radiocontrast Agent Production
        • 2.1.1 Global Radiocontrast Agent Revenue 2014-2025
        • 2.1.2 Global Radiocontrast Agent Production 2014-2025
        • 2.1.3 Global Radiocontrast Agent Capacity 2014-2025
        • 2.1.4 Global Radiocontrast Agent Marketing Pricing and Trends
      • 2.2 Radiocontrast Agent Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Radiocontrast Agent Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Radiocontrast Agent Production by Manufacturers
        • 3.1.1 Radiocontrast Agent Production by Manufacturers
        • 3.1.2 Radiocontrast Agent Production Market Share by Manufacturers
      • 3.2 Radiocontrast Agent Revenue by Manufacturers
        • 3.2.1 Radiocontrast Agent Revenue by Manufacturers (2014-2019)
        • 3.2.2 Radiocontrast Agent Revenue Share by Manufacturers (2014-2019)
      • 3.3 Radiocontrast Agent Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Radiocontrast Agent Production by Regions

      • 4.1 Global Radiocontrast Agent Production by Regions
        • 4.1.1 Global Radiocontrast Agent Production Market Share by Regions
        • 4.1.2 Global Radiocontrast Agent Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Radiocontrast Agent Production
        • 4.2.2 United States Radiocontrast Agent Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Radiocontrast Agent Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Radiocontrast Agent Production
        • 4.3.2 Europe Radiocontrast Agent Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Radiocontrast Agent Import & Export
      • 4.4 China
        • 4.4.1 China Radiocontrast Agent Production
        • 4.4.2 China Radiocontrast Agent Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Radiocontrast Agent Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Radiocontrast Agent Production
        • 4.5.2 Japan Radiocontrast Agent Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Radiocontrast Agent Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Radiocontrast Agent Consumption by Regions

      • 5.1 Global Radiocontrast Agent Consumption by Regions
        • 5.1.1 Global Radiocontrast Agent Consumption by Regions
        • 5.1.2 Global Radiocontrast Agent Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Radiocontrast Agent Consumption by Application
        • 5.2.2 North America Radiocontrast Agent Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Radiocontrast Agent Consumption by Application
        • 5.3.2 Europe Radiocontrast Agent Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Radiocontrast Agent Consumption by Application
        • 5.4.2 Asia Pacific Radiocontrast Agent Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Radiocontrast Agent Consumption by Application
        • 5.5.2 Central & South America Radiocontrast Agent Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Radiocontrast Agent Consumption by Application
        • 5.6.2 Middle East and Africa Radiocontrast Agent Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Radiocontrast Agent Breakdown Dada by Type
      • 6.2 Global Radiocontrast Agent Revenue by Type
      • 6.3 Radiocontrast Agent Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Radiocontrast Agent Breakdown Dada by Application
        • 7.2.1 Global Radiocontrast Agent Consumption by Application
        • 7.2.2 Global Radiocontrast Agent Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 GE Healthcare (US)
        • 8.1.1 GE Healthcare (US) Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.1.4 Radiocontrast Agent Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Bracco Imaging (Italy)
        • 8.2.1 Bracco Imaging (Italy) Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.2.4 Radiocontrast Agent Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Bayer HealthCare (Germany)
        • 8.3.1 Bayer HealthCare (Germany) Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.3.4 Radiocontrast Agent Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Guerbet (France)
        • 8.4.1 Guerbet (France) Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.4.4 Radiocontrast Agent Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Lantheus (US)
        • 8.5.1 Lantheus (US) Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.5.4 Radiocontrast Agent Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Daiichi Sankyo (Japan)
        • 8.6.1 Daiichi Sankyo (Japan) Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.6.4 Radiocontrast Agent Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Unijules Life Sciences (India)
        • 8.7.1 Unijules Life Sciences (India) Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.7.4 Radiocontrast Agent Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 J.B. Chemicals and Pharmaceuticals (India)
        • 8.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.8.4 Radiocontrast Agent Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Spago Nanomedicine (Sweden)
        • 8.9.1 Spago Nanomedicine (Sweden) Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.9.4 Radiocontrast Agent Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 Taejoon Pharm (South Korea)
        • 8.10.1 Taejoon Pharm (South Korea) Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Radiocontrast Agent
        • 8.10.4 Radiocontrast Agent Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 Jodas (India)
      • 8.12 Magnus Health (India)

      9 Production Forecasts

      • 9.1 Radiocontrast Agent Production and Revenue Forecast
        • 9.1.1 Global Radiocontrast Agent Production Forecast 2019-2025
        • 9.1.2 Global Radiocontrast Agent Revenue Forecast 2019-2025
      • 9.2 Radiocontrast Agent Production and Revenue Forecast by Regions
        • 9.2.1 Global Radiocontrast Agent Revenue Forecast by Regions
        • 9.2.2 Global Radiocontrast Agent Production Forecast by Regions
      • 9.3 Radiocontrast Agent Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Radiocontrast Agent Production Forecast by Type
        • 9.4.2 Global Radiocontrast Agent Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Radiocontrast Agent Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Radiocontrast Agent Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Radiocontrast Agent Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Radiocontrast Agent Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Radiocontrast Agent Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Radiocontrast Agent Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Radiocontrast Agent Upstream Market
        • 11.1.1 Radiocontrast Agent Key Raw Material
        • 11.1.2 Typical Suppliers of Key Radiocontrast Agent Raw Material
        • 11.1.3 Radiocontrast Agent Raw Material Market Concentration Rate
      • 11.2 Radiocontrast Agent Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Radiocontrast Agent Distributors
      • 11.5 Radiocontrast Agent Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Radiocontrast Agent . Industry analysis & Market Report on Radiocontrast Agent is a syndicated market report, published as Global Radiocontrast Agent Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Radiocontrast Agent market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,010.80
        4,516.20
        6,021.60
        3,588.00
        5,382.00
        7,176.00
        594,087.00
        891,130.50
        1,188,174.00
        328,107.00
        492,160.50
        656,214.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report